Solara Active Pharma Sciences Limited (BOM:890202)

BOM:890202 Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	27,935	20,499	24,661	13,353	11,787	23,977
Market Cap Growth	14.24%	-16.88%	84.69%	13.28%	-50.84%	-52.10%
Enterprise Value	34,294	26,948	33,026	23,165	21,509	31,550
Last Close Price	308.70	273.50	261.00	-	-	-
PE Ratio	-	-	4566.82	-	-	-
PS Ratio	2.03	1.49	1.92	1.04	0.82	1.89
PB Ratio	2.22	1.63	2.25	1.43	0.79	1.57
P/TBV Ratio	3.23	2.37	3.53	2.54	1.09	2.20
P/FCF Ratio	27.91	20.48	14.27	19.69	26.23	-
P/OCF Ratio	18.27	13.41	11.59	12.27	7.54	-
EV/Sales Ratio	2.49	1.96	2.57	1.80	1.49	2.49
EV/EBITDA Ratio	17.78	13.97	16.29	-	16.36	39.77
EV/EBIT Ratio	36.78	28.91	30.57	-	77.96	-
EV/FCF Ratio	34.26	26.92	19.10	34.16	47.86	-
Debt / Equity Ratio	0.55	0.55	0.73	1.08	0.67	0.68
Debt / EBITDA Ratio	3.56	3.56	3.87	-	7.55	12.63
Debt / FCF Ratio	6.86	6.86	4.61	14.92	22.54	-
Net Debt / Equity Ratio	0.50	0.50	0.72	1.07	0.67	0.65
Net Debt / EBITDA Ratio	3.28	3.28	3.91	-10.24	7.64	12.49
Net Debt / FCF Ratio	6.33	6.33	4.58	14.79	22.34	-2.20
Asset Turnover	0.60	0.60	0.56	0.49	0.49	0.46
Inventory Turnover	2.15	2.15	1.95	1.88	1.48	1.63
Quick Ratio	0.55	0.55	0.41	0.33	0.53	0.56
Current Ratio	0.96	0.96	0.77	0.64	1.08	1.17
Return on Equity (ROE)	-0.63%	-0.63%	0.05%	-46.49%	-1.47%	-3.74%
Return on Assets (ROA)	2.55%	2.55%	2.95%	-4.70%	0.59%	-0.58%
Return on Invested Capital (ROIC)	4.92%	4.94%	5.64%	-8.89%	1.10%	-1.15%
Return on Capital Employed (ROCE)	6.50%	6.50%	8.40%	-17.80%	1.50%	-1.40%
Earnings Yield	-0.27%	-0.36%	0.02%	-42.49%	-1.88%	-2.43%
FCF Yield	3.58%	4.88%	7.01%	5.08%	3.81%	-18.80%
Buyback Yield / Dilution	-10.54%	-10.54%	-4.44%	-6.13%	-0.15%	-4.75%
Total Shareholder Return	-10.54%	-10.54%	-4.44%	-6.13%	-0.15%	-4.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.